u/rina_bergstrom

the food noise going quiet is the effect people actually describe

Open-label extensions lose their randomisation.

alcohol_aversion is right about the programme names. They are different populations with different endpoints.

watch appetite, not the scale, for the first month

Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.

Nothing on this board is medical advice, and the people answering you — including me — are members with spreadsheets rather than clinicians.

Show the arithmetic — where did the unit figure come from?

Adding one thing — put the date on the label too. Concentration plus date and you can never mix two vials up.

What concentration did you actually reconstitute at, rather than what did you intend to?

STEP is semaglutide obesity, SURMOUNT is tirzepatide obesity, they are not interchangeable

Correction: that is a request for information, not a seizure notice. Different document, different process, different deadline.

Research-use-only labelling is a description of intended use, not a customs classification. It does not by itself determine how anything is treated at a border.

Week 94: 23kg down, constipation basically gone since about week 4, and the honest headline is that nothing dramatic happened. It was boring and it worked.

Push back: "nobody has tested them" is a fact about this board, not a fact about the company. Say the first one.

Reflux was the one that got me.

Disagreeing with this one line: that symptom is not on the wait-and-see list and should not be posted as though it is.

Nothing on this board is a taper schedule, and no member can write one for another.

Adding the one process step — write down where you are before you change anything.

the appetite signal and the scale move on different clocks

Gently disagree with the framing — nothing has gone wrong. Week 20 looking flat is the ordinary experience.

A report is useful here when it carries dates, the exact domain, what was requested, what arrived and what did not. Everything else is atmosphere.

Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.

Bought four different things to fix my nausea. What actually worked was eating half as fast.

Concentration is mass over volume, and a U-100 syringe reads 100 units per millilitre. Those two facts are the whole of the arithmetic this board keeps explaining.

I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.

Split one vial between Medutest and Janoshik. The two numbers were within half a point of each other and I stopped worrying about which lab to trust.

Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.

5mg into 1mL is 5mg/mL, and 0.5mg of that is 10 units

Push back: an open-label extension tells you about the people who stayed. That is a different question.

Disagree.

Disagreeing with this specific inference — that is a preclinical result being read as human pharmacology.

Was completely wrong about the gastric emptying story in a thread here two years ago. Someone corrected me with a citation and I have not made that mistake since.

Sat at 1.7mg for four months because it was doing the job.

Disagree with this specific line. A pause at 0.25mg is not evidence that 0.25mg has stopped working.

Adding more water does not change how much peptide is in the vial. It changes the concentration, which changes the volume you draw for the same amount. That is the entire relationship.

Correcting my own comment above: I said day three and my log says day two. Same pattern, wrong day.

Small fix — the shedding follows the rate of weight loss, not the compound, and it is temporary.

nausea that arrives on day two and fades by day four is the standard shape

I would separate the two claims. The site being newly registered is checkable. The motive you are inferring is not.

The press release said that; the publication says something more hedged. Worth reading both.

Stretched from seven days to ten to twelve over four months. Appetite told me where the limit was each time.

Nothing here is a training or nutrition prescription. Targets and programmes are matters for somebody who knows your history and your training background.

Careful — you have a plausible mechanism and no evidence that it is the operative one in the case you are describing.

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

write the concentration on the vial in marker, that is the whole post

Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.

Not convinced. Cross-trial comparison between two programmes with different populations and designs is not a comparison.